ING Groep NV Sells 28,656 Shares of The Clorox Company (NYSE:CLX)

ING Groep NV lessened its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 64.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,064 shares of the company's stock after selling 28,656 shares during the period. ING Groep NV's holdings in Clorox were worth $2,609,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Brooklyn Investment Group grew its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Clorox in the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after acquiring an additional 138 shares in the last quarter. Asset Planning Inc purchased a new stake in Clorox during the 4th quarter valued at $32,000. Finally, Catalyst Capital Advisors LLC bought a new stake in shares of Clorox in the 3rd quarter worth $54,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

NYSE CLX traded down $2.53 on Monday, hitting $154.72. 644,347 shares of the company traded hands, compared to its average volume of 1,332,846. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The business's 50 day moving average price is $157.72 and its 200-day moving average price is $159.96. The company has a market capitalization of $19.06 billion, a price-to-earnings ratio of 42.27, a P/E/G ratio of 2.62 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the firm posted $2.16 earnings per share. Equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Analyst Ratings Changes

CLX has been the topic of a number of research analyst reports. JPMorgan Chase & Co. upped their price target on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and increased their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Evercore ISI lifted their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.